Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Glenmark Pharm Glenmark Pharma Ltd. | BSE 2009.00 -0.95 (-0.05%) | NSE 2009.70 -0.90 (-0.04%) | Trade | Add

BSE Live

Dec 29, 16:01

2009.00 -0.95 (-0.05%)

Volume

AVERAGE VOLUME

5-Day

25,495

10-Day

17,687

30-Day

23,820

5,497

Prev. Close

2009.95
Open Price

2043.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Dec 29, 15:44

2009.70 -0.90 (-0.04%)

Volume

AVERAGE VOLUME

5-Day

684,687

10-Day

522,249

30-Day

979,576

266,984

Prev. Close

2010.60
Open Price

2012.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2009.70 (452)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Glenmark Pharma (in Rs. Cr.)	Mar 15	Mar 14	Mar 13	Mar 12	Mar 11
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	5,199.63	2,411.36	2,033.85	1,615.82	1,212.25
Less: Excise/Sevice Tax/Other Levies	200.42	137.80	98.57	69.00	58.70
Revenue From Operations [Net]	4,999.21	2,273.56	1,935.29	1,546.82	1,153.55
Total Operating Revenues	5,085.60	2,300.90	1,949.30	1,564.67	1,162.94
Other Income	84.94	67.13	116.25	55.10	71.75
Total Revenue	5,170.54	2,368.04	2,065.55	1,619.77	1,234.69
EXPENSES
Cost Of Materials Consumed	1,564.03	467.89	415.75	337.67	240.49
Purchase Of Stock-In Trade	173.95	159.97	141.09	104.95	87.16
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FG,WIP And Stock-In Trade	-69.65	-5.23	-3.67	-12.86	13.99
Employee Benefit Expenses	662.25	395.35	303.02	246.81	174.16
Finance Costs	30.19	30.98	43.69	60.87	85.75
Depreciation And Amortisation Expenses	119.46	30.20	25.04	21.11	20.99
Other Expenses	1,290.03	786.96	760.67	577.13	361.37
Total Expenses	3,770.26	1,866.11	1,685.60	1,335.67	983.90
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	1,400.28	501.92	379.95	284.10	250.79
Exceptional Items	-168.74	0.00	0.00	0.00	0.00
Profit/Loss Before Tax	1,231.55	501.92	379.95	284.10	250.79
Tax Expenses-Continued Operations
Current Tax	280.17	108.02	65.70	55.40	67.40
Less: MAT Credit Entitlement	52.69	47.76	65.70	37.47	28.62
Deferred Tax	-3.46	7.84	4.78	0.87	-0.17
Tax For Earlier Years	0.00	0.00	-10.93	0.00	0.00
Total Tax Expenses	224.02	68.10	-6.15	18.80	38.62
Profit/Loss After Tax And Before ExtraOrdinary Items	1,007.53	433.82	386.11	265.30	212.18
Profit/Loss From Continuing Operations	1,007.53	433.82	386.11	265.30	212.18
Profit/Loss For The Period	1,007.53	433.82	386.11	265.30	212.18
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	37.14	16.01	14.26	9.81	7.86
Diluted EPS (Rs.)	37.13	16.00	14.25	9.80	7.85
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials	359.92	33.54	31.41	20.58	9.17
Indigenous Raw Materials	1,149.08	421.85	372.43	312.00	225.37
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares	0.00	0.00	0.00	0.00	0.00
Indigenous Stores And Spares	55.02	12.50	11.91	5.10	5.95
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	54.26	54.25	54.17	54.11	10.81
Tax On Dividend	11.35	9.24	9.23	8.78	1.85
Equity Dividend Rate (%)	200.00	200.00	200.00	200.00	40.00